Catch up on stories from the past week (and beyond) at the Slashdot story archive

 



Forgot your password?
typodupeerror
DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Also, Slashdot's Facebook page has a chat bot now. Message it for stories and more. Check out the new SourceForge HTML5 Internet speed test! ×
Biotech

Submission + - Avastin Failure Highlights Drug Research Problems

SoyChemist writes: "When an FDA committee decided that blockbuster oncology drug Avastin should not be used to treat breast cancer because the risks outweigh the benefits, shares of Genentech stock plummeted. Rather than reciting financial figures, Business Week reporter Arlene Weintraub took a step back and painted a detailed picture of how the biotech company is trying to skirt major industry problems within the field of autoimmune disease research. Wired Science provided further analysis, explaining the importance increasing the variety of avoiding me too drugs, not rushing research, and using a personalized medicine approach."
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Avastin Failure Highlights Drug Research Problems

Comments Filter:

What is worth doing is worth the trouble of asking somebody to do.

Working...